Bristol-Myers Squibb Pharmaceuticals Limited
Manufacture of basic pharmaceutical products · Denham
ActiveUnited KingdomIncorporated 1990Private Limited Company
Financial position
Accounts to 2025-12-31 · GBP · Company accounts
Net assets
£197,901,000
Cash
£524,000
Turnover
—
Profit / loss
£13,055,000
Current assets
£223,209,000
Creditors < 1 year
£73,874,000
Equity
£197,901,000
Average employees
Not available
Balance-sheet trend
GBP · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
Some figures were read by AI from scanned accounts, so small errors are possible. View the filed accounts
| Reported figures | 2025-12-31Company · AI-read | 2024-12-31Company · AI-read |
|---|---|---|
| Balance sheet | ||
| Net assets | £197,901,000 | £185,713,000 |
| Equity | £197,901,000 | £185,713,000 |
| Assets | ||
| Fixed assets | £68,628,000 | £58,162,000 |
| Property, plant & equipment | £64,159,000 | £52,886,000 |
| Current assets | £223,209,000 | — |
| Cash at bank | £524,000 | £376,000 |
| Debtors | £146,226,000 | £111,262,000 |
| Stock | £76,459,000 | £100,457,000 |
| Liabilities | ||
| Creditors within one year | £73,874,000 | £73,366,000 |
| Creditors after one year | £14,000 | — |
| Provisions | £52,834,000 | £46,555,000 |
| Net current assets | £149,335,000 | £138,728,000 |
| Assets less current liabilities | £217,963,000 | £196,890,000 |
| Profit & loss | ||
| Profit / loss | £13,055,000 | £13,393,000 |
| Source evidence | View filing | View filing |
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
0 outstanding chargesNo charges available in our records.